Healthcare >> CEO Interviews >> May 7, 2001
PETER D. MELDRUM has served as the President and Chief Executive
Officer of Myriad Genetics, Inc., since 1992. Prior to joining
the company, Mr. Meldrum was President and Chief Executive
Officer of Founders Fund, Inc., a venture capital group. He
currently serves as a member of the Engineering National Advisory
Council, University of Utah College of Science Advisory Board and
the Executive Board of the Utah Life Sciences Association. Mr.
Meldrum was a member of the Governor's Council of Science and
Technology and chaired the Governor's Advisory Board concerning
the regulation of the biotechnology industry in Utah. Mr. Meldrum
was awarded the Governor's Medal for Science and Technology in
1998. He received an M.B.A. from the University of Utah in 1974
and a B.S. degree in chemical engineering in 1970. Profile
TWST: Could we begin with a brief, historical sketch of the company andthen a profile of the company as it is now?
Mr. Meldrum: Myriad Genetics is a biopharmaceutical company focused on
the